The Latin America Forum explores a number of critical topics focused on improving the quality in development and manufacturing of biopharmaceutical products.

The Netherlands Area Biotech (NLab) Discussion Group is the first CASSS discussion group located outside the US, and is intended to enable the local area community of industry, academic and regulatory professionals to meet and share ideas and experiences, thereby working together to resolve scientific challenges in the field of biopharmaceutical development and regulation.

The CGTP Summit will bring together industry, regulatory, and academic professionals to discuss pertinent challenges in the cell and gene therapy field. This one-day meeting will have an open format with deep dive discussions.

The Cell and Gene Therapy Products (CGTP) symposium enables the exchange of scientific ideas and dialogue with regulators that form the basis of evolving regulatory practices in the development of these diverse and innovative products.

This 2-day CMC forum will review the many initiatives that make up the next frontier in CMC.

The focus of this Symposium is the practical application of mass spectrometry (MS) in the biotechnology industry. Mass Spectrometry is a critical analytical technology used in the discovery, development, and commercialization of biopharmaceuticals.

International Symposium on Higher Order Structure of Protein Therapeutics. Protein higher-order structure (HOS) and dynamics are essential to protein function.

The Latin America Forum explores a number of critical topics focused on improving the quality in development and manufacturing of biopharmaceutical products.

The goal of this symposium is to provide a forum for the discussion of recent developments in capillary electrophoresis (CE) analysis of protein, nucleotide and small molecule pharmaceuticals.

The Forum will follow the established model of the CMC Forum series with focus on topics and regulatory updates relevant for Europe.

The Latin America Forum explores a number of critical topics focused on improving the quality in development and manufacturing of biopharmaceutical products.

The Japan Forum will follow the established model of the CMC Forum series with focus on topics and regulatory updates relevant for Japan and Asia Pacific. The Forum strives to share information with the regulatory agencies to assist them in merging good scientific and regulatory practices.

The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion on relevant CMC issues throughout the lifecycle of a product.

It is with great pleasure that the WCBP Scientific Organizing Committee invites you to WCBP 2024.

Bioassays: Scientific Approaches and Regulatory Strategies is a premier bioassay symposium that presents a truly unique opportunity for attendees to interact with key industry thought leaders and discuss topics such as current perspectives, strategies and technologies used for bioassays.